Abcellera Biologics Stock Forecast

Buy or Hold candidate since May 20, 2026 Gain 48.80%

The AbCellera Biologics Inc. stock price fell by -6.72% on the last day (Friday, 10th Jul 2026) from $7.29 to $6.80. During the last trading day the stock fluctuated 10.39% from a day low at $6.60 to a day high of $7.29. The price has fallen in 6 of the last 10 days but is still up by 2.1% over the past 2 weeks. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 7 million shares were bought and sold for approximately $49.19 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 74.96% during the next 3 months and, with a 90% probability hold a price between $10.60 and $15.05 at the end of this 3-month period.

ABCL Signals & Forecast

The AbCellera Biologics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $7.49. On a fall, the stock will find some support from the long-term average at approximately $6.15. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -16.26%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for AbCellera Biologics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $6.03 and $5.24. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AbCellera Biologics Inc. finds support just below today's level at $6.03. If this is broken, then the next support from accumulated volume will be at $5.24 and $5.14.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.686 between high and low, or 10.39%. For the last week, the stock has had daily average volatility of 10.39%.

Our recommended stop-loss: $6.47 (-4.78%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (ABCL) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect AbCellera Biologics Inc. to open at $6.90, and during the day (based on 14 day Average True Range), to move between $6.48 and $7.12, which gives a possible trading interval of +/-$0.637 (+/-9.83%) up or down from last closing price. If AbCellera Biologics Inc. takes out the full calculated possible swing range there will be an estimated 9.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.10 (4.41%) than the support at $6.03 (11.32%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is AbCellera Biologics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AbCellera Biologics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.635 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $6.90 ( 1.44%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk